FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00760916 · WITHDRAWN

Trial details

NCT number: NCT00760916
Sponsor: United Therapeutics
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2008-12-01
Primary completion: 2009-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.